Drug intelligence / Profile preview

PBCAR269B

Development stage
Preclinical
Lead developer
Precision BioSciences
Modality
CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

PBCAR269B is an investigational **allogeneic BCMA-directed CAR-T cell therapy** being developed by Precision BioSciences for relapsed or refractory multiple myeloma. It is a next-generation successor to PBCAR269A and is engineered using the company's ARCUS genome editing platform to target **B-cell maturation antigen** on malignant plasma cells while incorporating **stealth cell** features intended to reduce host immune recognition and improve persistence of donor-derived CAR-T cells. The program was described as being in IND-enabling development with plans for IND filing in early 2022, indicating a preclinical-stage off-the-shelf cell therapy designed for antimyeloma immunotherapy.

Other names
allogeneic anti-BCMA CAR-T cell therapy
02

Targets

BCMA (B-cell maturation antigen)

Beyond the preview

Go deeper on PBCAR269B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PBCAR269B.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call